AstraZeneca vaccine

Photo: NPR

AstraZeneca Sells $2.2 Billion Worth COVID-19 Vaccines: Report

Drugmaker AstraZeneca reported that it sold more than $2.2 billion worth of COVID-19 vaccines in the past nine months. Earlier, the company promised to provide jabs on a not-for-profit basis through the pandemic. However, the company is expecting to progressively transition the vaccine to 'profitability'. AstraZeneca also reported that it will be creating more vaccine units under its plans for the future of the Pandemic. 

Fri, 12 Nov 2021 - 08:32 PM / by SAM RAHUL RAJASHEKHAR

Tags: Covid-19, astrazenca, Coronavirus Vaccines, England, Vaccine Sale

Courtesy: The Guardian

COVID-19 Vaccine.

Photo: Al Jazeera

Pfizer And AstraZeneca Prove To Be More Than 90% Effective Against Delta Variant

Analysis of the Public Health England stated that Pfizer is 96% effective and AstraZeneca is 92% effective against hospitalisation from the Delta variant of COVID-19 on June 14. They also stated the necessity of getting the second dose on time for the complete effectiveness of the vaccines. These percentages are comparable with vaccine effectiveness against hospitalisation from the Alpha variant, which was first identified in the UK.

Wed, 16 Jun 2021 - 01:39 PM / by Sohini Mandal

Tags: Pfizer-BioNTech, astrazenca, Delta, Alpha 1, Indian COVID-19 variant, Covid-19 Vaccine

Courtesy: The Economic Times

Oxford-AstraZeneca Covid-19 vaccine's clinical trials to resume.

Photo: DNA India

Oxford-AstraZeneca COVID-19 Vaccine Trials Resume in UK

Oxford University on September 12 confirmed that the trials of the COVID-19 vaccine, which is being developed in collaboration with AstraZeneca, has been resumed in UK. The university stated, "Following the recommendations of both the independent safety review committee and the UK regulator, trials will recommence." The vaccine is now in phase-3 trials and was halted on September 8 owing to an adverse reaction in one of the participants.

Sun, 13 Sep 2020 - 09:22 AM / by Sneha Ramesh

Tags: health care, Coronavirus Vaccines, Oxford University, astrazenca

Courtesy: The Economic Times

Representational image of Cargo aircrafts

Photo: CNN

8,000 Jumbo Jets Required to Deliver COVID Vaccine to 7.8 Billion: IATA

Approximately 8,000 jumbo-jets will be needed to deliver Coronavirus vaccine, warned International Air Transport Association (IATA). Alerting it to be the biggest challenge aviation industry has faced, IATA asked governments to plan their logistics chain for swift movement of vaccines. Vaccines storage will also require specific temperature, hence not all planes would be suited to carry them. IATA further stated that some operators have… read-more

Thu, 10 Sep 2020 - 04:31 PM / by Nitesh Kumar Singh

Tags: Coronavirus Vaccines, Supply chain , astrazenca, Covid-19, Covid-19 Vaccine

Courtesy: The Guardian


Photo: The Indian Express

Oxford-AstraZeneca Coronavirus Vaccine's Trials Shelved Citing Safety Review

The trials of the coronavirus vaccine, developed by AstraZeneca and Oxford University, has been shelved as one of the participants showed an adverse reaction. However, AstraZeneca spokesperson said, "Standard review process triggered a pause to vaccination to allow review of safety data." However, the details regarding the adverse effect have not been revealed. The trials are in the final stage, and are being conducted in various countries… read-more

Wed, 09 Sep 2020 - 10:42 AM / by Sneha Ramesh

Tags: Coronavirus, Coronavirus Vaccines, Oxford University, astrazenca

Courtesy: The Hindu